You searched for bevacizumab - MPR

Your search for bevacizumab returned 3 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Diana Ernst, RPh remove

Your search for bevacizumab returned 3 results

Sort Results:

Relevant Recent
News

Biosimilars Mvasi, Kanjinti Now Available in the US

Mvasi (bevacizumab-awwb), a biosimilar to Avastin (bevacizumab), and Kanjinti (trastuzumab-anns), a biosimilar to Herceptin (trastuzumab) have been made available by Amgen and Allergan.  Mvasi, a vascular endothelial growth factor inhibitor, is indicated to treat: Metastatic colorectal cancer, in combination with intravenous 5-fluorouracil-based chemotherapy for first- or second-line treatment.  Metastatic colorectal cancer, in combination with fluoropyrimidine-irinotecan-…
News

First-Line Treatments for Advanced EGFR-Mutated NSCLC Compared

In patients with advanced epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), treatment with osimertinib and gefitinib plus pemetrexed-based chemotherapy was found to be superior to other first-line therapies, according to a systematic review and network meta-analysis published in the BMJ. For this investigation, study authors searched various databases from inception through May…